Status:
UNKNOWN
Validation of the ApneaScan Algorithm in Sleep Disordered Breathing
Lead Sponsor:
Royal Brompton & Harefield NHS Foundation Trust
Collaborating Sponsors:
Boston Scientific Corporation
Conditions:
Sleep-Disordered Breathing
Heart Failure
Eligibility:
All Genders
18+ years
Brief Summary
Sleep disordered breathing, in which patients my breath deeply, shallowly or stop breathing for periods whilst asleep, is common in heart failure and associated with a poor prognosis. This study aims ...
Detailed Description
72 patients with heart failure with reduced ejection fraction (HFREF) who have been selected to receive an Implantable Cardioverter-Defibrillator (ICD) or Cardiac Resynchronization Therapy Pacemaker o...
Eligibility Criteria
Inclusion
- Heart failure with reduced ejection fraction (EF \< 40%)
- Due to receive a device with ApneaScan function
- Able to give informed consent
- Ambulatory
Exclusion
- Known sleep disordered breathing on Non-Invasive Ventilation therapy.
Key Trial Info
Start Date :
March 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2017
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT02204865
Start Date
March 1 2014
End Date
October 1 2017
Last Update
November 9 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royal Brompton and Harefield NHS Trust
London, London, United Kingdom, SW3 6NP